Site Map
Japanese
Business Unit
Pipeline
Social Responsibility
Corporate profile
Our Message
Corporate governance
Operation
Corporate history
List of offices
Business Unit
Ohara Pharmaceutical:Our mission
Orphan drugs (pharmaceuticals for rare medical conditions) business
Generic drugs business
Corporate profile
Our Message
Corporate governance
Operation
Corporate history
List of offices
News Release
トップ
>
English
>
News Release
>
Initiation of a Phase I/II Clinical Study of “OP-10” in Japan
Initiation of a Phase I/II Clinical Study of “OP-10” in Japan
April 1, 2020
Initiation of a Phase I/II Clinical Study of “OP-10” in Japan
«
View List
»
